Browsing by Author Ciruelos, Eva

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
19-May-2016Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal ResistanceManso, Luis; Mourón, Silvana; Tress, Michael; Gómez López, Gonzalo; Morente, Manuel M.; Ciruelos, Eva; Rubio Camarillo, Miriam; Rodríguez Peralto, José Luis; Pujana Genestar, M. Ángel; Pisano, David G.; Quintela Fandino, Miguel
1-Jan-2021COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryGarrigós, Laia; Saura, Cristina; Martinez-Vila, Clara; Zambelli, Alberto; Bower, Mark; Pistilli, Barbara; Lambertini, Matteo; Ottaviani, Diego; Diamantis, Nikolaos; Lumsden, Ailsa; Pernas, Sònia; Generali, Daniele; Seguí, Elia; Viñas, Gemma; Felip, Eudald; Sánchez, Ana; Rizzo, Gianpiero; Santoro, Armando; Cortellini, Alessio; Perone, Ylenia; Chester, John; Iglesias, María; Betti, Marta; Vincenzi, Bruno; Libertini, Michela; Mazzoni, Francesca; Zoratto, Federica; Berardi, Rossana; Guida, Annalisa; Wuerstlein, Rachel; Loizidou, Angela; Sharkey, Rachel; Aguilar Company, Juan; Matas, Marta; Saggia, Chiara; Chiudinelli, Lorenzo; Colomba-Blameble, Emeline; Galazi, Myria; Mukherjee, Uma; Van Hemelrijck, Mieke; Marin, Mar; Strina, Carla; Prat Aparicio, Aleix; Pla, Helena; Ciruelos, Eva; Bertuzzi, Alexia; Mastro, Lucia del; Porzio, Giampiero; Newsom-Davis, Thomas; Ruiz, Isabel; Delany, Maria Belen; Krengli, Marco; Fotia, Vittoria; Viansone, Alessandro; Chopra, Neha; Romeo, Margarita; Salazar Soler, Ramón; Pérez Catalán, Ignacio; D’Avanzo, Francesca; Franchi, Michela; Milani, Manuela; Pommeret, Fanny; Tucci, Marco; Pedrazzoli, Paolo; Harbeck, Nadia; Ferrante, Daniela; Pinato, David J.; Gennari, Alessandra
1-Oct-2021Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL studyKahan, Zsuzsanna; Gil Gil, Miguel; Ruiz Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo, Begoña; Margeli, Mireia; Antón, Antonio; Casas, Maribel; Csöszi, Tibor; Murillo, Laura; Morales, Serafín; Calvo, Lourdes; Lang, Istvan; Alba, Emilio; Haba Rodriguez, Juan de la; Ramos, Manuel; Álvarez López, Isabel; Gal Yam, Einav; García Palomo, Andrés; Alvarez, Elena; González Santiago, Santiago; Rodríguez, César A.; Servitja, Sonia; Corsaro, Massimo; Rodrigálvarez, Graciela; Zielinski, Christoph; Martín, Miguel
28-Apr-2023HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancerOlivera Salguero, Rubén; Seguí, Elia; Cejalvo, Juan Miguel; Oliveira, Mafalda; Tolosa, Pablo; Vidal, Maria; Malumbres, Marcos; Gavilá, Joaquín; Saura, Cristina; Pernas, Sònia; López, Rafael; Margelí Vila, Mireia; Balmaña, Judith; Muñoz, Montserrat; Blancas, Isabel; Boni, Valentina; Ciruelos, Eva; Galve Calvo, Elena; Perelló, Antonia; Sánchez Bayona, Rodrigo; Cruz, Susana de la; Hoya, Miguel de la; Galván, Patricia; Sanfeliu, Esther; González Farré, Blanca; Sirenko, Valeria; Blanch Torras, Aura; Canes, Jordi; Masanas, Helena; Olmos, Rosa; Forns, Margarita; Prat Aparicio, Aleix; Casas, Ana; Pascual, Tomás
9-Jul-2021Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE StudyGil Gil, Miguel; Bellet, Meritxell; Bergamino Sirvén, Milana; Morales, Serafín; Barnadas, Agustí; Manso, Luís; Saura, Cristina; Fernández Ortega, Adela; Garcia Martinez, Elena; Martinez Jañez, Noelia; Melé, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Martin, X.; Ciruelos, Eva; Pernas, Sònia
18-Sep-2019Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trialAdamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; Gonzalez Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix
1-Apr-2021Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARLMartin, M.; Zielinski, C.; Ruiz Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo de las Heras, Begoña; Margelí Vila, Mireia; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M. I.; Murillo, L.; Morales, S.; Alba, Emilio; Gal Yam, E.; Guerrero Zotano, A.; Calvo, L.; Haba Rodríguez, J. de la; Ramos, M.; Álvarez López, Isabel; García Palomo, Andrés; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; García Sáenz, José Ángel; Chacón, José Ignacio; Swift, C.; Thallinger, C.; Gil Gil, Miguel
20-Jan-2020Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockadeBrasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix
9-Jan-2019Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trialGavilá, Joaquín; Oliveira, Mafalda; Pascual, Tomás; Perez-Garcia, Jose; Gonzàlez, Xavier; Canes, Jordi; Paré, Laia; Calvo Serrano, Isabel; Ciruelos, Eva; Muñoz Mateu, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andrés, Raquel; Perelló, Antonia; Martínez, Jerónimo; Morales, Serafín; Marín Aguilera, Mercedes; Martínez, Debora; Quero, Juan C.; Llombart-Cussac, Antonio; Prat Aparicio, Aleix
23-Apr-2021SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerPascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix
1-Jul-2021The role of CDK4/6 inhibitors in early breast cancerGil Gil, Miguel; Alba, Emilio; Gavilá, Joaquín; Haba Rodríguez, Juan de la; Ciruelos, Eva; Tolosa, Pablo; Candini, Daniele; Llombart Cussac, Antonio